5F-MDMB-PICA

From WikiMD's Wellness Encyclopedia

5F-MDMB-PICA

Synthetic cannabinoid


{{Drugbox | verifiedrevid = 477318464 | IUPAC_name = Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate | image = 5F-MDMB-PICA_structure.png | width = 200 | legal_uk = Class B | legal_us = Schedule I | legal_ca = Schedule II | legal_de = Anlage II | CAS_number = 1971007-92-7 | PubChem = 119025022 | ChemSpiderID = 52085000 | UNII = 7J1X0F7F3V | C=20 | H=28 | F=1 | N=3 | O=3 | smiles = CC(C)(C)C(C(=O)OC)NC(=O)c1cn(CCCCC(F)F)c2c1cccc2 | StdInChI = 1S/C20H28FN3O3/c1-20(2,3)17(19(26)27-4)23-18(25)16-14-12-10-9-11-13(14)15(22-16)7-5-6-8-21/h9-12,17H,5-8H2,1-4H3,(H,22,23,25) | StdInChIKey = QWZQXKZQXQXQXQ-UHFFFAOYSA-N }}

5F-MDMB-PICA is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the CB1 receptor and has been associated with numerous cases of severe toxicity and fatalities.

Chemical Structure and Properties[edit | edit source]

5F-MDMB-PICA is chemically classified as an indazole-based synthetic cannabinoid. Its IUPAC name is Methyl 2-[[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino]-3,3-dimethylbutanoate. The compound has a molecular formula of C20H28FN3O3 and a molecular weight of 377.46 g/mol.

Pharmacology[edit | edit source]

5F-MDMB-PICA acts as a potent agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The compound has a high binding affinity for the CB1 receptor, leading to strong psychoactive effects. It has been reported to cause severe adverse effects, including seizures, tachycardia, and acute kidney injury.

Legal Status[edit | edit source]

5F-MDMB-PICA is classified as a Schedule I controlled substance in the United States, indicating that it is considered to have a high potential for abuse and no accepted medical use. In the United Kingdom, it is classified as a Class B drug under the Misuse of Drugs Act 1971. It is also controlled under various international regulations.

Health Risks[edit | edit source]

The use of 5F-MDMB-PICA has been associated with numerous health risks. These include severe toxicity, psychosis, and death. The compound has been linked to multiple cases of overdose and has been found in various forensic toxicology reports.

Related Compounds[edit | edit source]

5F-MDMB-PICA is structurally related to other synthetic cannabinoids such as 5F-ADB, MDMB-CHMICA, and AB-FUBINACA. These compounds share similar pharmacological profiles and have been associated with similar adverse effects.

See Also[edit | edit source]

References[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD